INVESTORS

Zafgen (Nasdaq:ZFGN) is a biopharmaceutical company that has leveraged its proprietary MetAP2 biology platform to pioneer the study of MetAP2 inhibitors in both common and rare metabolic disorders.

Day High:
Day Low:  
Volume:    

Copyright West LLC. Minimum 15 minutes delayed.

  • Intra
  • 3 mo.
  • 6 mo.
  • 1 yr.

Widget - Stock Chart

EVENTS & PRESENTATIONS